“…3,4 Cycloprodigiosin, another member of the prodigiosin family, induces apoptosis in various cancer cell lines including acute human T-cell leukemia, 17 promyelocytic leukemia, 18 human and rat hepatocellular cancer, 19 human breast cancer, 20 and TNF-stimulated human cervix carcinoma (HeLa). 21 The National Cancer Institute (Bethesda) has also shown that prodigiosin has an average IC 50 of 2.1 mM against a panel of 57 different human cancer cell lines (this information is available on the Internet at www.dtp.nci.nih.gov the NSC number for prodigiosin is 47147-F). Interestingly, we demonstrate in this paper that prodigiosin induces apoptosis in B-CLL cells with an IC 50 of 116725 nM.…”